XML 75 R14.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Goodwill and Intangible Assets
3 Months Ended
Oct. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets

Note 8 – Goodwill and Intangible Assets 

Intangible assets consist of the following at:

   October 31,  July 31,
   2019  2019
In-Process Research & Development  $8,761,427   $8,761,427 
Non-compete agreements   1,566,700    1,210,000 
Developed software/technology   172,500    131,000 
Vendor agreements and other intangibles   775,674    51,274 
    11,276,301    10,153,701 
Less accumulated amortization   (473,859)   (319,432)
   $10,802,442   $9,834,269 

Intangible assets are generally amortized on a straight-line basis over the useful lives of the assets. The Company is currently not amortizing the in-process research and development until it becomes commercially viable and placed in service. At the time when the intangible assets are placed in service the Company will determine a useful life.

Amortization expense amounted to $154,426 and $646 for the three months ended October 31, 2019 and October 31, 2018, respectively.

The remaining estimated amortization expense for the next five years and thereafter is as follows:

 

Year Ending July 31,  Amount
2020  $570,708 
2021   616,744 
2022   246,324 
2023   94,511 
2024   68,491 
Thereafter   444,658 
   $2,041,435 

Changes in the value of goodwill:

Balance as of July 31, 2019  $38,297,573 
Acquisition of MediSource and Pantheon   603,553 
Balance as of October 31, 2019  $38,901,126